Notably, SMOC2 expression further decreased in the metastatic cancer cells in the lymph nodes compared to primary PTC (Fig. 3b), suggesting a functional implication of SMOC2 down-regulation in the metastatic progression of PTC. This evidence concerns the gene SMOC2 and cancer.